snow
Events - Slide 1 Events - Slide 2 Events - Slide 3 Events - Slide 4

Welcome to Retina Specialists Northwest

Dedicated to delivering compassionate excellence in retinal and inflammatory eye disease always.

Retina Specialists Northwest, PLLC is an ophthalmic subspecialty practice focused on Retina and Uveitis. The practice philosophy is summarized in the company motto: Compassionate Excellence Always.

Board certified eye physician and surgeon, Dr. Brenda Myers-Powell

Dr. Myers-Powell and her staff are committed to delivering the best in personalized retinal care efficiently and effectively. Our pledge is to understand you as a whole and to provide the best available medical and surgical treatment tailored to your needs. We are centrally located between Seattle and Tacoma, at West Campus in Federal Way, strategically positioned to deliver quality care to residents within and outside the metropolitan areas. Our office is easily accessible from I-5, Hwy-18, Hwy-167, and Hwy-99. For your convenience, we are open most Saturdays.

We utilize the latest technology as well as clinical expertise to diagnose and manage all retinal and inflammatory disorders with particular attention to Retinal Tear and Detachment, Disorders of the Vitreous, Macular Holes, Diabetic Retinopathy, Age-related Macular Degeneration, Retinal Vascular Disease, Macular Edema, Scleritis, and vision-threatening Uveitis.

Ultra-Widefield Multifocal Electroretinography and Visual Evoked Potentials

Retina Specialists Northwest is proud to announce the implementation of Diagnosys Ultra-Widefield Multifocal Electroretinography (mfERG) and Visual Evoked Potentials (VEP) as part of our service. This diagnostic tool can significantly benefit those with retinal and optic nerve disease.

Retina Specialists Northwest has invested in elevating the level of care in the Puget Sound area by providing a valuable service that had previously been unavailable in our community.

The mfERG can objectively assess cone dysfunction and macular disease facilitating diagnosis and assessment of progression of macular disorders such as Retinal Dystrophy, ARMD, Diabetic Retinopathy and Drug Toxicity. The AAO has listed mfERG as a critical test modality for screening for Plaquenil Toxicity.

VEP can assess optic nerve function, improving the diagnosis and management of Optic Neuritis and Optic Neuropathy. This is particularly useful in Multiple Sclerosis.

Our Federal Way office will provide this service at your patients' convenience.

Call (253) 517-3334 to schedule an appointment.

News from NEI

NEI Remembers Robert “Bob” Nussenblatt (1948-2016)

Robert Nussenblatt, M.D., chief of the Laboratory of Immunology at the National Eye Institute (NEI), died on April 17 at age 67. Dr Nussenblatt began working at NEI, part of the National Institutes of Health in Bethesda, Maryland, in 1977, and proved himself to be a tireless scientist, research leader, mentor, clinician, and patient advocate.

04/19/16 2:26 pm

Fish and Insects Guide Design for Future Contact Lenses

Making the most of the low light in the muddy rivers where it swims, the elephant nose fish survives by being able to spot predators amongst the muck with a uniquely shaped retina, the part of the eye that captures light. In a new study, researchers looked to the fish’s retinal structure to inform the design of a contact lens that can adjust its focus.

English

03/14/16 8:26 am

NEI Employment Program for People with Intellectual Disabilities Celebrates 10 Years

Andrew Butler may be one of the hardest working people at NIH. He has to be, because he works at the Building 49 Central Animal Facility at the Bethesda, Md. campus—home to the many rodents and other laboratory animals that are a vital part of NIH research. Andrew’s daily shift in the cage wash and facility support area starts at 7:00 am each day, but he arrives promptly at 6:15 am.

03/10/16 8:31 am

Eylea Outperforms Avastin for Diabetic Macular Edema with Moderate or Worse Vision Loss

A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those receiving Avastin (bevacizumab), but only among participants starting treatment with 20/50 or worse vision. Gains after two years were about the same for Eylea and Lucentis (ranibizumab), contrary to year-one results from the study, which showed Eylea with a clear advantage.

English

02/25/16 6:46 am

Uncorrected Farsightedness Linked to Literacy Deficits in Preschoolers

A study funded by the National Eye Institute (NEI), part of the National Institutes of Health, has shown that uncorrected farsightedness (hyperopia) in preschool children is associated with significantly worse performance on a test of early literacy.

English

01/26/16 7:59 am